SCHEMBL2701203

SCHEMBL2701203

Cc1c[c]cc2cc3ccccc3cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 8/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ HPGD P15428 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ MAPT P10636 2/20 0.39
▸ CYP2A6 P11509 6/20 0.38
▸ NQO1 P15559 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.37
▸ TSHR P16473 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ GAA P10253 2/20 0.33
▸ HSD17B1 P14061 1/20 0.33
▸ HSD17B2 P37059 1/20 0.33
▸ ELANE P08246 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ CYP1B1 Q16678 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL148866 0.80 CYP2A6 (0.52) CYP1A2ALDH1A1HPGDHSD17B10CYP2A6
SCHEMBL2252631 0.75 ALDH1A1 (0.40) CYP1A2ALDH1A1HPGDHSD17B10MAPT
SCHEMBL2253560 0.75 MCL1 (0.40) ALDH1A1HSD17B10MAPTNQO1KDM4E
SCHEMBL5747406 0.75 CYP1A2 (0.38) CYP1A2ALDH1A1HPGDMAPTCYP2A6
SCHEMBL2252019 0.75 NQO1 (0.57) CYP1A2ALDH1A1HPGDHSD17B10MAPT
SCHEMBL2701259 0.73 CYP1A2 (0.49) CYP1A2ALDH1A1HPGDHSD17B10MAPT
SCHEMBL2701310 0.73 CYP1A2 (0.49) CYP1A2ALDH1A1HPGDHSD17B10MAPT
SCHEMBL130783 0.73 CYP1A2 (0.69) CYP1A2ALDH1A1HPGDHSD17B10MAPT
SCHEMBL5746939 0.72 CA1 (0.43) ALDH1A1MAPTCYP2A6TSHRKDM4E
SCHEMBL2257372 0.72 HSD17B1 (0.40) CYP1A2ALDH1A1HPGDHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3064997-B1 LAMINATE AND USE OF A KIT FOR MANUFACTURING OF A LAMINATE FUJIFILM CORP (JP) 2021-04-28 — — EP disclosed
US-10833272-B2 Laminate and kit FUJIFILM CORPORATION (JP) 2020-11-10 — — US disclosed
CN-105683835-B Laminated body, organic semiconductor manufacture are manufactured with set group and organic semiconductor uses light resistance composition 富士胶片株式会社 2019-11-26 — — CN disclosed
US-10439139-B2 — — 2019-10-08 — — US disclosed
CN-105474099-B Laminated body 富士胶片株式会社 2019-09-03 — — CN disclosed
CN-103091986-B Positive-type photosensitive resin composition, cured film and forming method thereof, liquid crystal display device and organic electroluminescence display device and method of manufacturing same 富士胶片株式会社 2018-05-18 — — CN disclosed
CN-102955361-B Positive-type photosensitive resin composition, the forming method of cured film, cured film, liquid crystal display device and organic EL display 富士胶片株式会社 2018-04-06 — — CN disclosed
US-9929376-B2 Laminate, kit for manufacturing organic semiconductor, and resist composition for manufacturing organic semiconductor FUJIFILM CORPORATION (JP) 2018-03-27 — — US disclosed
US-20180040824-A1 LAMINATE AND KIT FUJIFILM CORPORATION (JP) 2018-02-08 — — US disclosed
EP-2818462-B1 CYCLIC AZINE DERIVATIVES, PROCESSES FOR PRODUCING THESE, AND ORGANIC ELECTROLUMISCENT ELEMENT CONTAINING THESE AS COMPONENT TOSOH CORP (JP) 2017-11-08 — — EP disclosed
EP-2498133-A2 Resin pattern, method for producing the pattern, method for producing MEMS structure, method for manufacturing semiconductor device, and method for producing plated pattern Fujifilm Corporation (JP) 2012-09-12 — — EP disclosed
US-20120214993-A1 CYCLIC AZINE DERIVATIVES, PROCESSES FOR PRODUCING THESE, AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THESE AS COMPONENT SAGAMI CHEMICAL RESEARCH INSTITUTE, (JP) 2012-08-23 — — US disclosed
EP-2468731-A1 CYCLIC AZINE DERIVATIVES, PROCESSES FOR PRODUCING THESE, AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THESE AS COMPONENT Tosoh Corporation (JP) 2012-06-27 — — EP disclosed
US-20120107563-A1 PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING PATTERN, MEMS STRUCTURE, METHOD FOR PRODUCING THE STRUCTURE, METHOD FOR DRY ETCHING, METHOD FOR WET ETCHING, MEMS SHUTTER DEVICE, AND IMAGE DISPLAY APPARATUS FUJIFILM CORPORATION (JP) 2012-05-03 — — US disclosed
EP-2447773-A1 Photosensitive resin composition, method for producing pattern, MEMS structure, method for producing the structure, method for dry etching, method for wet etching, MEMS shutter device, and image display apparatus Fujifilm Corporation (JP) 2012-05-02 — — EP disclosed
CN-102193316-A Positive photosensitive resin composition, formation method of curing film, curing film, organic el display device and liquid crystal display device FUJI PHOTO FILM CO LTD 2011-09-21 — — CN disclosed
CN-100565964-C organic electroluminescent element IDEMITSU KOSAN CO (JP) 2009-12-02 — — CN disclosed
CN-101069299-A Organic electroluminescent element IDEMITSU KOSAN CO (JP) 2007-11-07 — — CN disclosed
US-20060293503-A1 Polyaminopyridines and method for producing same SUMITOMO SEIKA CHEMICALS CO., LTD (JP) 2006-12-28 — — US disclosed
EP-1669390-A1 POLYAMINOPYRIDINES AND METHOD FOR PRODUCING SAME SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2006-06-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120214993-A1 CYCLIC AZINE DERIVATIVES, PROCESSES FOR PRODUCING THESE, AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THESE AS COMPONENT CPNE4, EPB41, AZI2 CYP1A2 1801/4885ALDH1A1 267/4885HPGD 4413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback